MRK $89.19 0.38 (0.4%)

    MRK Profile

    MRK trades on the NYSE.

    MEMBERSHIP
    Dow Industrials S&P 500 Dogs Of The Dow
    SECTOR
    Health Care
    MARKET CAPITALIZATION

    $227 Billion

    Large-Cap
    TWITTER

    Merck

    Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States.

    MRK Earnings

    EPS

    0.74

    P/E

    33.85

    Q2 Earnings for Apr, May & Jun

    Tue, Jul 30, 2019

    Since Earnings Report

    MRK +8.1%

    Q3 Earnings for Jul, Aug & Sep

    Tue, Oct 29, 2019

    Since Earnings Report

    MRK +8.5%

    MRK Dividend

    Dividend Yield

    2.74%

    Dividend Rate

    $2.44

    Ex-Dividend Date

    Fri, Dec 13, 2019

    Dividend Pay Date

    Wed, Jan 8, 2020

    Dividend Frequency

    Quarterly

    Dividend Payments

    1,911 Payments

    MRK Charts

    52WL $70.89
    52WH $89.96
    All-Time $96.69


    MRK Industry Competitors


    BIOTECH & PHARMA
    Johnson & Johnson
    Pfizer
    Bristol-Myers Squibb
    Amgen
    Novo Nordisk A/S
    AbbVie
    Eli Lilly
    Sanofi SA (ADR)
    Gilead Sciences
    Celgene



    Symbol MC DY Price Day YTD
    MRK $227.48 2.74% $89.19 -0.4% 18.0%






        TOP    




    info@symbolsurfing.com


    Symbol Surfing

    ©2019 Symbol Surfing All Rights Reserved.

    Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

    Cookies Policy Terms Of Service Privacy Policy